sever
acut
respiratori
syndrom
sar
emerg
infecti
diseas
caus
novel
coronaviru
cov
variant
sar
cov
epidem
sar
cov
highli
transmiss
human
decemb
case
identifi
worldwid
peopl
die
mortal
rate
world
health
organ
statist
http
wwwwhointcsrsarscountryt
although
sar
epidem
success
contain
juli
pathogenesi
sar
cov
remain
poorli
understood
viral
envelop
sar
cov
contain
least
three
structur
membran
protein
spike
membran
small
membran
envelop
e
protein
cellular
receptor
sar
cov
receptorbind
domain
rbd
protein
identifi
indic
rbd
region
protein
play
critic
role
neutral
antibodi
induct
angiotensinconvert
enzym
bind
viral
entri
absenc
protein
express
e
protein
induc
detect
serum
sarscovneutr
antibodi
respons
e
protein
requir
assembl
viral
particl
protein
dispens
incorpor
present
isol
sar
cov
himalayan
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procyonoid
wild
live
market
china
suggest
viru
may
origin
anim
reservoir
recent
two
independ
group
report
identif
sarslik
coronaviru
slcov
differ
chines
horsesho
bat
speci
provid
strong
evid
bat
could
serv
natur
reservoir
sar
cov
code
sequenc
slcov
isol
bat
display
low
level
similar
isol
human
civet
e
protein
slcov
high
sequenc
similar
human
civet
worthi
note
nucleotid
sequenc
ident
among
coronavirus
differ
sourc
greatli
increas
region
exclud
host
rang
coronavirus
report
correl
degre
protein
variat
suggest
variat
protein
respons
interspeci
transmiss
adapt
new
host
viruslik
particl
vlp
repres
specif
class
subunit
vaccin
mimic
structur
authent
viru
particl
vlp
present
viral
antigen
authent
conform
subunit
vaccin
readili
recogn
immun
system
mani
studi
document
vlp
capabl
induc
bcellmedi
immun
respons
highli
effect
stimul
cell
prolifer
cytotox
lymphocyt
ctl
respons
stimul
activ
ebola
marburg
hiv
vlp
dendrit
cell
dc
previou
investig
indic
unlik
nativ
viru
vlp
effect
stimul
dc
enhanc
innat
adapt
immun
respons
previou
studi
describ
vlp
form
e
protein
sar
cov
elicit
strong
sar
covspecif
humor
cellular
immun
respons
mice
howev
whether
slcov
vlp
elicit
cytokin
secret
orand
activ
human
dc
remain
determin
studi
investig
whether
protein
slcov
isol
bat
incorpor
vlp
form
e
protein
human
sar
cov
addit
vitro
infect
model
bat
slcov
far
establish
intend
use
vlp
altern
studi
immun
respons
induc
dc
therefor
compar
phenotyp
function
chang
immatur
dc
inocul
bvlp
sar
cov
vlp
sspecif
immun
activ
confirm
mice
use
dna
vaccin
find
describ
report
may
signific
understand
evolut
pathogenesi
sar
cov
bs
gene
amplifi
rtpcr
clone
pfastbac
dual
vector
recombin
baculoviru
vacb
gener
follow
transfect
cell
recombin
baculoviru
vacm
express
e
protein
sar
cov
strain
genbank
access
number
previous
describ
vlp
form
e
protein
sar
cov
success
construct
previou
studi
use
baculoviru
system
main
variat
slcov
sar
cov
human
civet
locat
protein
studi
whether
bs
protein
incorpor
vlp
form
e
protein
sarscov
coinfect
cell
recombin
baculovirus
vacb
vacm
h
coinfect
cell
collect
thinsect
prepar
examin
shown
figur
numer
viral
particl
nm
diamet
mainli
observ
cytoplasm
infect
cell
western
blot
immunogold
label
subsequ
perform
detect
incorpor
bs
vlp
shown
figur
presenc
bs
e
protein
detect
bvlp
use
antisar
cov
antibodi
correspond
band
neg
control
preimmun
rabit
antiserum
genom
differ
slcov
sar
cov
larg
locat
gene
particularli
end
region
equival
code
region
therefor
surpris
serum
rais
human
sar
cov
recogn
bat
slcov
protein
code
region
protein
highli
conserv
use
specif
bat
region
aa
antibodi
figur
gold
particl
detect
around
bvlp
immunogold
label
analysi
confirm
result
western
blot
addit
antibodi
also
recogn
human
sar
cov
vlp
vlp
form
e
protein
absenc
protein
figur
taken
togeth
data
indic
bs
protein
slcov
success
incorpor
vlp
form
e
protein
human
sar
cov
immatur
dc
incub
bvlp
h
express
costimulatori
molecul
matur
marker
analyz
dc
treat
pb
ac
use
neg
control
shown
fig
similar
lpstreat
dc
four
marker
upregul
much
higher
level
pb
actreat
dc
fig
collect
result
indic
bvlp
lead
activ
matur
dc
contrast
heat
bvlp
induc
much
lower
level
express
dc
suggest
structur
protein
incorpor
vlp
essenti
dc
activ
matur
dc
matur
lead
upregul
adhes
costimulatori
molecul
also
result
secret
proinflammatori
cytokin
activ
innat
adapt
immun
respons
assess
effect
bvlp
dc
immatur
dc
treat
variou
condit
supernat
collect
cytokin
tnfalpha
quantif
proinflammatori
cytokin
antiinflammatori
cytokin
shown
fig
incub
dc
bvlp
significantli
enhanc
secret
level
three
cytokin
similar
lpstreat
dc
boiledbvlp
lost
abil
induc
cytokin
product
secret
fold
lower
heat
bvlpstreat
dc
bvlpstreat
dc
although
secret
level
still
fold
higher
pb
ac
treat
group
enhanc
like
due
nonspecif
stimul
remain
denatur
protein
heat
bvlp
moreov
cytokin
secret
profil
similar
dc
inocul
bvlp
without
polymyxin
b
pretreat
exclud
possibl
lp
contamin
contrast
lpstreat
dc
significantli
lost
cytokinesecret
abil
polymyxin
b
pretreat
combin
flow
cytometri
result
fig
reason
draw
conclus
structur
bvlp
lp
contamin
contribut
cytokin
product
bvlpstreat
dc
previous
construct
sar
cov
vlp
investig
humor
cellular
immun
respons
induc
sar
cov
vlp
mice
whether
sar
cov
vlp
activ
dc
remain
address
current
studi
either
sar
cov
vlp
bvlp
incub
immatur
dc
express
surfac
maker
secret
cytokin
subsequ
analyz
similar
lp
treatment
sar
cov
vlp
bvlp
enhanc
express
fig
howev
bvlp
show
stronger
abil
induc
secret
fold
higher
respect
secret
il
similar
fig
differ
sar
cov
vlp
bvlp
lie
protein
differ
induct
highli
like
due
variat
two
protein
understand
type
cell
stimul
vlpsexpos
dc
intracellular
stain
measur
flow
cytometri
show
fig
popul
cell
stimul
either
bvlp
sar
cov
vlpstreat
dc
much
higher
popoul
pb
actreat
group
percentag
popul
cell
signific
differ
thu
bvlp
sar
cov
vlp
treat
dc
could
polar
th
cell
toward
phenotyp
balanc
respons
infecti
agent
influenc
pathogen
growth
immunopatholog
cellular
immun
may
crucial
factor
longterm
protect
viru
infect
observ
differ
dcstimul
activ
sar
cov
vlp
bvlp
like
due
protein
confirm
conclus
clone
bs
gene
construct
recombin
plasmid
pcdna
pcdnab
respect
two
plasmid
immun
mice
intramuscularli
everi
two
week
ten
day
final
immun
measur
determin
humor
immun
respons
profil
elisa
shown
fig
antisarscov
igg
subtyp
profil
reveal
induc
immun
regimen
although
level
similar
level
pcdnab
vaccin
group
appreci
higher
pcdna
immun
group
elispot
assay
also
use
assess
magnitud
sspecif
tcell
respons
mice
vaccin
pcdna
pcdnab
compar
pcdna
immun
antigenspecif
cell
number
higher
cell
number
time
higher
mice
immun
pcdnab
p
fig
moreov
group
induc
much
higher
level
comb
higher
elev
bs
immun
reason
draw
conclus
bs
protein
could
induc
stronger
bia
immun
respons
protein
spike
protein
sar
cov
key
protein
involv
viral
entri
therefor
main
target
vaccin
design
http
absenc
protein
express
structur
protein
e
protein
induc
detect
neutral
antibodi
respons
antibodi
sar
cov
protein
inhibit
pulmonari
viral
replic
protect
sar
cov
challeng
variat
protein
dramat
affect
virul
host
tropism
viru
instanc
slcov
isol
bat
display
greater
genet
variat
sar
cov
human
civet
intend
investig
whether
protein
slcov
isol
bat
incorpor
viral
like
particl
vlp
form
e
protein
human
sar
cov
whether
vlp
activ
dc
use
baculoviru
express
system
construct
bvlp
incorpor
e
protein
human
sar
cov
protein
slcov
bat
electron
microscopi
em
detect
confirm
format
vlp
similar
morpholog
nativ
viru
western
blot
indic
bs
protein
incorpor
bvlp
major
differ
protein
sar
cov
slcov
locat
region
region
conserv
success
incorpor
slcov
protein
vlp
form
e
protein
sar
cov
suggest
bvlp
like
assembl
region
region
genomefre
bvlp
form
structur
protein
differ
speci
provid
us
physic
mean
investig
immunogen
immun
cell
sar
cov
mainli
target
lung
tissu
clinic
syndrom
sar
indic
host
immun
system
greatli
damag
dendrit
cell
dc
antigenpres
cell
play
key
role
innat
adapt
immun
exposur
dc
infecti
sar
cov
lead
phenotyp
function
matur
dc
includ
costimulatori
molecul
express
cellstimul
cytokin
product
addit
uvinactiv
sar
cov
also
activ
immatur
dc
studi
demonstr
bvlp
morpholog
antigen
similar
nativ
viru
exhibit
stimul
abil
dc
induc
dc
matur
enhanc
express
cellsurfac
costimulatori
molecul
includ
essenti
optim
activ
cell
phenotyp
matur
dc
expos
bvlp
similar
observ
dc
incub
lipopolysaccharid
lp
wellknown
stimul
dc
matur
contrast
heatdenatur
bvlp
lost
abil
enhanc
express
cell
surfac
molecul
secret
cytokin
suggest
specif
structur
viral
protein
might
significantli
contribut
immun
modul
activ
taken
togeth
data
indic
baculoviru
derivedbvlp
interact
human
dc
induc
dc
matur
activ
previou
studi
found
vlp
form
e
protein
human
sar
cov
elicit
strong
sar
covspecif
humor
cellular
immun
respons
mice
confer
protect
immun
infect
protein
pseudotyp
murin
leukemia
virus
mlv
show
bvlp
sar
cov
vlp
activ
dc
induc
dc
matur
enhanc
express
costimulatori
molecul
matur
marker
studi
sar
covinfect
patient
indic
level
markedli
increas
acut
stage
return
normal
given
adequ
immunosuppress
treatment
corticosteroid
use
treatment
sar
basi
proinflammatori
cytokin
respons
immunopatholog
lung
interest
current
studi
bvlp
induc
much
higher
level
sar
cov
vlp
seem
bvlp
vs
dc
serv
better
model
simul
acutephas
respons
viru
host
thu
model
may
applic
develop
vaccin
drug
viru
import
proinflammatori
cytokin
mediat
apoptosi
immun
inflamm
may
play
import
role
antivir
respons
inflamm
previou
studi
wang
et
al
indic
protein
sar
cov
play
key
role
product
proinflammatori
cytokin
stage
virushost
cell
interact
protein
could
activ
signal
pathway
thu
upregul
secret
demonstr
bvlp
stronger
immun
modul
term
dc
activ
matur
sinc
differ
sar
cov
vlp
bvlp
protein
incorpor
enhanc
immun
modul
abil
bvlp
like
contribut
protein
differ
type
dc
may
play
differ
role
onset
immun
respons
balanc
cell
import
may
determin
outcom
immun
respons
toward
infect
allergi
therefor
studi
influenc
bvlpsstimul
dc
cell
polar
intracellular
cytokin
stain
compar
mocktreat
dc
bvlpsexpos
dc
increas
popul
posit
cell
secret
level
much
higher
indic
bia
immun
respons
matur
dc
enhanc
nativ
cell
differenti
result
confirm
bvlp
induc
dc
activ
matur
bvlp
stronger
abil
stimul
dc
induc
product
studi
address
whether
differ
protein
specif
construct
two
recombin
plasmid
pcdna
pcdnab
detect
immun
respons
mice
higher
level
higher
number
proteinspecif
cell
mice
immun
pcdnab
indic
protein
bat
sl
cov
immunogen
vivo
data
provid
evid
differ
immun
modul
abil
bvlp
sarscov
vlp
highli
like
contribut
protein
taken
togeth
success
construct
bvlp
form
membran
protein
differ
origin
one
slcov
isol
bat
bs
two
e
human
sar
cov
form
bvlp
demonstr
stimul
activ
immatur
dc
absenc
vitro
cell
cultur
model
slcov
studi
togeth
demonstr
bvlp
vs
dc
use
model
studi
interact
slcov
host
cell
studi
use
model
may
provid
import
inform
vaccin
develop
understand
pathogenesi
evolut
slcov
dna
code
protein
bs
bat
slcov
amplifi
strain
genbank
access
number
revers
transcriptionpolymeras
chain
reaction
rtpcr
use
follow
primer
gaattcttatgtgtagtgtaattttac
bs
gene
clone
pfastbac
dual
vector
control
strong
viral
promot
polyhedron
promot
gfp
gene
clone
control
promot
gener
pfb
recombin
baculovirus
gener
use
autographa
californica
multipl
nucleopolyhedroviru
acmnpv
genom
brief
vacb
gener
transfect
bs
plasmid
insect
cell
use
lipofectin
invitrogen
recombin
baculoviru
vacm
gener
previous
describ
addit
bs
gene
subclon
invitrogen
carlsbad
calif
construct
recombin
plasmid
pcdna
pcdnab
respect
accuraci
construct
confirm
restrict
digest
sequenc
dna
plasmid
purifi
use
qiagen
megaprep
column
qiagen
dissolv
endotoxinfre
pb
final
concentr
store
insect
cell
coinfect
vacb
vacm
multipl
infect
moi
day
postinfect
cell
medium
harvest
centrifug
g
hour
bvlp
pellet
resuspend
pb
purifi
discontinu
wv
sucros
gradient
visibl
band
sucros
layer
collect
concentr
centrifug
resuspend
pb
total
protein
concentr
measur
eppendorf
biophotomet
germani
puriti
vlp
check
sdspage
presenc
bs
protein
purifi
prepar
confirm
western
blot
use
rabbitderiv
antisarscov
antibodi
kindli
provid
prof
linfa
wang
australian
anim
health
laboratori
bt
eaton
lf
wang
unpublish
result
immunogold
label
detect
use
antiserum
aa
region
bat
protein
gener
antiserum
cdna
aa
region
clone
express
vector
neb
protein
purifi
use
amylos
resin
neb
use
immun
rabbit
em
studi
bvlp
bud
insect
cell
cell
coinfect
vacb
vacm
moi
h
postinfect
cell
collect
fix
glutaraldehyd
osmium
tetroxid
thinsect
sampl
prepar
examin
transmiss
electron
microscop
immunogold
label
bvlp
load
onto
collodionco
em
grid
min
remov
excess
sampl
solut
antibodi
protein
ad
onto
grid
incub
h
room
temperatur
grid
wash
three
time
incub
nm
gold
conjug
antirabbit
igg
h
sampl
stain
phosphotungst
acid
pta
min
drain
examin
em
human
peripher
blood
mononuclear
cell
pbmc
isol
healthi
donor
isopaqueficol
lymphoprep
nycom
oslo
norway
follow
manufactur
instruct
immatur
dc
gener
pbmc
previous
describ
minor
modif
briefli
pbmc
rpmi
gibco
laboratori
grand
island
ny
cultur
sixwel
plate
cellsml
hour
adher
monocyt
wash
rpmi
cultur
day
complet
medium
contain
fetal
calf
serum
life
technolog
supplement
rhgmcsf
uml
uml
peprotech
half
medium
replac
everi
two
day
result
differenti
dc
posit
posit
particip
gave
written
inform
consent
studi
conduct
accord
declar
hubei
approv
health
depart
hubei
provinc
wuhan
blood
center
hubei
provinc
china
dc
cell
incub
either
bvlp
lipopolysaccharid
lp
sigma
st
loui
mo
meanwhil
immatur
dc
treat
pb
ac
cultur
supernat
cell
transfect
baculoviru
express
vector
pfastbac
dual
gfp
control
promot
heatdenatur
bvlp
min
altern
equival
amount
bvlp
lp
incub
polymyxin
b
compound
bind
lp
inactiv
lp
biolog
function
room
temperatur
h
ad
dc
differ
treatment
dc
h
supernat
remov
frozen
cytokin
detect
dc
stain
specif
cellsurfac
marker
analyz
flow
cytometri
cultur
supernat
collect
cytokin
tnfa
quantif
use
enzymelink
immunosorb
assay
elisa
accord
manufactur
instruct
ucytech
sensit
pgml
dc
surfac
marker
analyz
flow
cytometri
briefli
cell
wash
cold
pb
cell
surfac
stain
carri
use
follow
antibodi
fluorescein
isothiocyan
fitc
conjug
fitcconjug
phycoerythrin
pe
conjug
peconjug
pharmingen
incub
antibodi
min
cell
wash
analyz
use
flow
cytomet
beckman
epic
altra
usa
data
analyz
use
exopo
analysi
softwar
minimum
event
collect
analyz
sampl
isotypematch
control
peconjug
fitcconjug
bd
pharmingen
includ
stain
cell
prepar
pbmc
posit
select
use
antibodi
bd
pharmingen
puriti
consist
immatur
dc
expos
bvlp
ac
pb
h
wash
thoroughli
treat
dc
cocultur
cell
plate
costar
triplic
anoth
h
intracellular
detect
dcst
cell
mixtur
stimul
ngml
pma
phorbol
ionomycin
h
stimul
mononsesin
ad
well
plate
incub
h
block
reaction
cell
wash
fix
permeabil
intracellular
peconjug
stain
flow
cytometri
analysi
beckman
epic
altra
usa
perform
success
data
analyz
use
exopo
analysi
softwar
minimum
event
collect
analyz
sampl
isotypematch
control
peconjug
bd
pharmingen
includ
stain
wkold
femal
balbc
mice
immun
intramuscularli
purifi
plasmid
pcdna
pcdnab
time
interv
sspecif
igg
subclass
serum
assess
elisa
recombin
protein
express
e
coli
purifi
use
detect
antigen
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
sigma
use
secondari
antibodi
optic
densiti
od
read
nm
cellular
immun
respons
sarscov
assess
elispot
assay
use
mous
splenocyt
assay
perform
accord
instruct
manual
ucytech
netherland
absorb
read
use
elispot
reader
hitech
instrument
spotform
cell
sfc
per
splenocyt
calcul
medium
background
respons
absenc
antigen
consist
sfc
per
splenocyt
data
present
immun
mice
per
group
spss
softwar
window
use
statist
analysi
lsd
ttest
use
group
comparison
p
valu
consid
statist
signific
